Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Palliative care in heart failure: facts and numbers.

Riley JP, Beattie JM.

ESC Heart Fail. 2017 May;4(2):81-87. doi: 10.1002/ehf2.12125. Epub 2016 Dec 28.

2.

Decision-Making Experiences of Patients with Implantable Cardioverter Defibrillators.

Green AR, Jenkins A, Masoudi FA, Magid DJ, Kutner JS, Leff B, Matlock DD.

Pacing Clin Electrophysiol. 2016 Oct;39(10):1061-1069. doi: 10.1111/pace.12943. Epub 2016 Sep 22.

PMID:
27566614
3.

Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study.

MacIver J, Tibbles A, Billia F, Ross H.

SAGE Open Med. 2016 Apr 7;4:2050312116642693. doi: 10.1177/2050312116642693. eCollection 2016.

4.

Hospice Use Following Implantable Cardioverter-Defibrillator Implantation in Older Patients: Results From the National Cardiovascular Data Registry.

Kramer DB, Reynolds MR, Normand SL, Parzynski CS, Spertus JA, Mor V, Mitchell SL.

Circulation. 2016 May 24;133(21):2030-7. doi: 10.1161/CIRCULATIONAHA.115.020677. Epub 2016 Mar 25.

5.

Implantable Cardioverter-Defibrillator Use in Older Adults: Proceedings of a Hartford Change AGEnts Symposium.

Kramer DB, Matlock DD, Buxton AE, Goldstein NE, Goodwin C, Green AR, Kirkpatrick JN, Knoepke C, Lampert R, Mueller PS, Reynolds MR, Spertus JA, Stevenson LW, Mitchell SL.

Circ Cardiovasc Qual Outcomes. 2015 Jul;8(4):437-46. doi: 10.1161/CIRCOUTCOMES.114.001660. Epub 2015 Jun 2. Review. No abstract available.

6.

A study to improve communication between clinicians and patients with advanced heart failure: methods and challenges behind the working to improve discussions about defibrillator management trial.

Goldstein NE, Kalman J, Kutner JS, Fromme EK, Hutchinson MD, Lipman HI, Matlock DD, Swetz KM, Lampert R, Herasme O, Morrison RS.

J Pain Symptom Manage. 2014 Dec;48(6):1236-46. doi: 10.1016/j.jpainsymman.2014.03.005. Epub 2014 Apr 21.

7.

Features and outcomes of patients who underwent cardiac device deactivation.

Buchhalter LC, Ottenberg AL, Webster TL, Swetz KM, Hayes DL, Mueller PS.

JAMA Intern Med. 2014 Jan;174(1):80-5. doi: 10.1001/jamainternmed.2013.11564.

8.

Resynchronization: considering device-based cardiac therapy in older adults.

Kramer DB, Reynolds MR, Mitchell SL.

J Am Geriatr Soc. 2013 Apr;61(4):615-21. doi: 10.1111/jgs.12174. Epub 2013 Mar 21. Review.

9.

Age differences in the use of implantable cardioverter-defibrillators among older patients hospitalized with heart failure.

Hess PL, Grau-Sepulveda MV, Hernandez AF, Peterson ED, Bhatt DL, Schwamm LH, Yancy CW, Fonarow GC, Al-Khatib SM; Get with The Guidelines Steering Committee and Hospitals..

J Cardiovasc Electrophysiol. 2013 Jun;24(6):664-71. doi: 10.1111/jce.12100. Epub 2013 Feb 25.

10.

Patient preferences for deactivation of implantable cardioverter-defibrillators.

Dodson JA, Fried TR, Van Ness PH, Goldstein NE, Lampert R.

JAMA Intern Med. 2013 Mar 11;173(5):377-9. doi: 10.1001/jamainternmed.2013.1883. No abstract available.

11.

Deactivation of pacemakers and implantable cardioverter-defibrillators.

Kramer DB, Mitchell SL, Brock DW.

Prog Cardiovasc Dis. 2012 Nov-Dec;55(3):290-9. doi: 10.1016/j.pcad.2012.09.003. Review.

12.

Life-saving devices reach the end of life with heart failure.

Matlock DD, Stevenson LW.

Prog Cardiovasc Dis. 2012 Nov-Dec;55(3):274-81. doi: 10.1016/j.pcad.2012.10.007. Review.

13.

The deactivation of implantable cardioverter-defibrillators: medical, ethical, practical, and legal considerations.

Carlsson J, Paul NW, Dann M, Neuzner J, Pfeiffer D.

Dtsch Arztebl Int. 2012 Aug;109(33-34):535-41. doi: 10.3238/arztebl.2012.0535. Epub 2012 Aug 20. Review.

14.

Spiritual well-being may buffer psychological distress in patients with implantable cardioverter defibrillators (ICD).

Salmoirago-Blotcher E, Crawford S, Tran C, Goldberg R, Rosenthal L, Ockene I.

J Evid Based Complementary Altern Med. 2012 Oct 1;17(3):148-154. Epub 2012 May 25.

15.

Critical appraisal of cardiac implantable electronic devices: complications and management.

Padeletti L, Mascioli G, Perini AP, Grifoni G, Perrotta L, Marchese P, Bontempi L, Curnis A.

Med Devices (Auckl). 2011;4:157-67. doi: 10.2147/MDER.S15059. Epub 2011 Sep 9.

16.

The dilemma of implantable cardioverter-defibrillator therapy in the geriatric population.

Revenco D, Morgan JP, Tsao L.

J Geriatr Cardiol. 2011 Sep;8(3):195-200. doi: 10.3724/SP.J.1263.2011.00195.

17.

The use of advance directives among patients with implantable cardioverter defibrillators.

Tajouri TH, Ottenberg AL, Hayes DL, Mueller PS.

Pacing Clin Electrophysiol. 2012 May;35(5):567-73. doi: 10.1111/j.1540-8159.2012.03359.x. Epub 2012 Mar 20.

18.
19.

Informed consent in cardiac resynchronization therapy: what should be said?

Kramer DB, Brock DW, Tedrow UB.

Circ Cardiovasc Qual Outcomes. 2011 Sep;4(5):573-7. doi: 10.1161/CIRCOUTCOMES.111.961680. Review. No abstract available.

20.

Cardiac care for older adults. Time for a new paradigm.

Forman DE, Rich MW, Alexander KP, Zieman S, Maurer MS, Najjar SS, Cleveland JC Jr, Krumholz HM, Wenger NK.

J Am Coll Cardiol. 2011 May 3;57(18):1801-10. doi: 10.1016/j.jacc.2011.02.014. No abstract available.

Supplemental Content

Support Center